Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jespersen

Showing results (201-210 of 204) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 204 results.
Thrombosis and Haemostasis|May 3, 2013
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart DiseaseR De Caterina, S Husted, L Wallentin, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2008
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosageL Poller, M Keown, S Ibrahim, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2017
International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plainA M H P van den Besselaar, V Chantarangkul, F Angeloni, et al.
European Journal of Epidemiology|September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, J Danesh, S Erqou, et al.
Pageof 21

Showing results (201-210 of 204) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 204 results.
Thrombosis and Haemostasis|May 3, 2013
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart DiseaseR De Caterina, S Husted, L Wallentin, et al.
Journal of Thrombosis and Haemostasis : JTH|May 21, 2008
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosageL Poller, M Keown, S Ibrahim, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2017
International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plainA M H P van den Besselaar, V Chantarangkul, F Angeloni, et al.
European Journal of Epidemiology|September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, J Danesh, S Erqou, et al.
Pageof 21